A Director at Pain Therapeutics (PTIE) is Buying Shares


Today, a Director at Pain Therapeutics (NASDAQ: PTIE), Sanford Robertson, bought shares of PTIE for $63.34K.

This recent transaction increases Sanford Robertson’s holding in the company by 608.98% to a total of $123.6K.

See today’s analyst top recommended stocks >>

Currently, Pain Therapeutics has an average volume of 1.86M.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Pain Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of novel drugs. Its drug candidate includes REMOXY, which is a strong painkiller with a unique formulation designed to reduce potential risks of unintended use. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.

Read More on PTIE:

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts